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congestive pathology of the liver, the sinusoidal obstruction syn-
drome. Thus, sinusoidal obstruction syndrome following chemo-
therapy is associated with blood stasis inside sinusoids and
patients with this syndrome have heterogenous hypointensities
(decreased uptake) at magnetic resonance imaging (MRI) after
injection of the hepatobiliary contrast agent Gd-EOB-DTPA [3].
In rats treated with monocrotaline (a toxic that induces sinusoi-
dal obtruction syndrome), the hepatic concentrations and bile
excretion of Gd-BOPTA are also lower than in control rats
(Fig. 1) [4]. Gd-BOPTA is another hepatobiliary contrast agent
close to Gd-EOB-DTPA that enters rat hepatocytes through rat
Oatps and is excreted into bile through the canalicular trans-
porter rat Mrp2 [5,6]. Interestingly, rats with sinusoidal obstruc-
tion syndrome have decreased regeneration rates following
partial hepatectomy (70%).
The study by Kawaguchi et al. [1] reinforces the growing
interest in hepatobiliary compounds that use the OATPs/MRP2
pathway through hepatocytes to evaluate the hepatic function
of patients. Dyes (ICG), MR contrast agents (Gd-BOPTA and
Gd-EOB-DTPA), and tracers (99mTc-mebrofenin) have been
evaluated and the results of these studies are summarized in
several recent reviews [7–9]. These articles describe how clear-
ance tests and liver imaging with hepatobiliary compounds
improve the scoring of hepatic function. Moreover, imaging
the entire liver with dyes, contrast agents, or tracers offers an
advantage over plasma biomakers since it studies all segments
of the liver [10]. However, as pointed out by the authors, trans-
port through this pathway does not represent all functions of
hepatocytes.
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imaging. Radiology 2011;260:727–733.Reply to: ‘‘Portal uptake function in veno-occlusive regions evaluated
by real-time ﬂuorescent imaging using indocyanine green’’To the Editor:
We have read with interest the comments made by Kobbe et al.
to our recently published article, which demonstrated that portal
uptake of indocyanine green (ICG) in veno-occlusive regions
caused by dissection of the major hepatic veins decreased to
approximately 40% of that in non-veno-occlusive regions (rang-
ing from 10% to 80%) by using intraoperative ﬂuorescence imag-
ing [1]. In veno-occlusive hepatic regions, the portal veins can act
as drainage of arterial blood ﬂow, according to the severity of
venous occlusion. Thus, we hypothesized that, in hepatic regions1with severe venous occlusion, ICG ﬂowed into the sinusoids from
the hepatic arteries and portal veins following intravenous
administration, but regurgitated and drained into the portal sys-
tem before reaching the hepatocytes, leading to the decreased
concentration of ICG in the hepatic parenchyma. This should be
conﬁrmed in further studies by using in vivo ﬂuorescence micros-
copy [2], which may enable visualization of intrahepatic micro-
vascular blood ﬂow in the veno-occlusive regions.
Although the decreased portal uptake of ICG in the early
phase of the hepatic venous occlusion would be caused by the3 vol. 59 j 631–640
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intrahepatic hemodynamic changes, postoperative functional and
regenerative disorders in veno-occlusive hepatic regions may be
associated with the altered expression of hepatic transporters,
as pointed out by Kobbe et al. We have evaluated expression levels
of hepatic uptake transporters for ICG (organic anion-transporting
polypeptide 8 [OATP8, SLCO1B3] and Na+/taurocholate co-trans-
porting polypeptide [NTCP, SLC10A1]) [3] by using immunohisto-
chemical staining and gene expression analysis, in order to
elucidate mechanistic background of ICG accumulation in hepato-
cellular carcinoma following preoperative intravenous adminis-
tration, which enables real-time identiﬁcation of cancerous
tissues during hepatectomy [4]. It would be valuable to assess
the expression levels of hepatic transporters in veno-occlusive
and non-veno-occlusive regions, if postoperative tissue samples
are available to adopt similar approach. Gadoxetic acid-enhanced
magnetic resonance imaging is a good alternative to evaluate
postoperative portal uptake and excretion function in veno-occlu-
sive and non-veno-occlusive hepatic regions, although it should
be noted that gadoxetic acid can be excreted not only into bile
through multidrug resistance-associated protein 2 (MRP2), but
also into blood sinusoids through MRP3 [5], while ICG is exclu-
sively excreted into the bile canaliculus through MRP2.
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drug moni
To the Editor:
Rau and colleagues described the impact of genetic polymor-
phisms in SLC28 genes, encoding concentrative nucleoside trans-
porter 2 (CNT2) and 3 (CNT3) and inosine triphosphatase (ITPA)
variants, on ribavirin (RBV) serum levels, hemoglobin drop, and
therapeutic response in patients with HCV infection [1]. In their
paper, they cited our observation that single nucleotide polymor-
phism (SNP) in the SLC28A2 encoding region (rs11854484) is an
independent predictor of sustained virological response (SVR)
[2,3]. Our hypothesis was that this effect could be explained by
the different ability of CNT2 forms to internalize RBV within cells,
and not by a direct effect on RBV plasma levels.
In the era of dual PEG-interferon (PegIFN)/RBV therapy, most
of the studies that investigated the role of RBV pharmacokinetics
(Pk) found a clear association between higher RBV exposure and a
higher chance of both SVR and anaemia, as expected on the basis
of the recognized proportionality between RBV daily dose and
these two outcomes [4]. Even in most recent studies, where
patients were stratiﬁed according to human genetic polymor-
phisms, RBV Pk retained its signiﬁcant role in predicting both
efﬁcacy and toxicity in PegIFN/RBV intakers [2,3,5–7]. While the
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ology 2010;256:817–826.sure: Genetics or therapeutic
toring?
need for RBV as part of new triple therapies has been proven in
development trials [8], it remains to be determined whether
RBV Pk has still any impact on treatment outcomes with highly
effective direct acting antivirals (DAAs). Then, the ability to early
predict, with genetics or therapeutic drug monitoring (TDM),
ribavirin plasma concentrations at steady state retains its clinical
importance.
Rau and colleagues described the association between CNT2
SNPs and RBV plasma concentrations. It should be noted that
these PK/PG analyses were conducted on 67 patients only, with-
out dose correction veriﬁcation, including patient with modiﬁed
dosage. In addition, they only reported a trend for statistical sig-
niﬁcance for the association of RBV concentration and SLC28
genotypes [1]. Our observations did not support this association
[2,3]: CNT2 SNPs were not associated with plasma RBV concen-
trations (after 4 weeks) while adjusting for the dose pro kilogram
and for dose reduction, and only using several SNPs (rs11854484,
rs2413775 and rs1060896) in ‘‘unfavorable’’ (for lower ribavirin
concentrations) combinations (on 186 HCV+ patients), it was pos-
sible to demonstrate a statistical signiﬁcance (p = 0.009) (Fig. 1).
On the contrary, week 4 RBV plasma exposure seems to be nicely
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